Deep Value Reports

PHVS Stock Risk & Deep Value Analysis

Pharvaris N.V.

DVR Score

8.2

out of 10

Hidden Gem

The Bottom Line on PHVS

We analyzed Pharvaris N.V. using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran PHVS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Sep 5, 2025•Run Fresh Analysis →

PHVS Deep Value Analysis

Pharvaris shows strong 10x potential with its oral HAE treatment (PHVS416), addressing a significant unmet need with compelling clinical data. The company has a clear vision, sufficient cash runway, and experienced leadership, supported by institutional investors. FDA approval is a major near-term catalyst. While regulatory risk is inherent and commercialization faces competition, the differentiated product and solid execution mitigate 'dud' flags, positioning it for substantial growth if approved.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More